Tonghua Dongbao Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 0.76%

Tonghua Dongbao Pharmaceutical Co Ltd (600867) has an Asset Resilience Ratio of 0.76% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Tonghua Dongbao Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥63.00 Million

≈ $9.22 Million USD Cash + Short-term Investments

Total Assets

CN¥8.25 Billion

≈ $1.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Tonghua Dongbao Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 600867 asset base.

Liquid Assets Composition Over Time

This chart breaks down Tonghua Dongbao Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600867 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥63.00 Million	0.76%
Total Liquid Assets	CN¥63.00 Million	0.76%

Asset Resilience Insights

Limited Liquidity: Tonghua Dongbao Pharmaceutical Co Ltd maintains only 0.76% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Tonghua Dongbao Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tonghua Dongbao Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Piramal Pharma Limited NSE:PPLPHARMA	Drug Manufacturers - Specialty & Generic	0.73%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%

Annual Asset Resilience Ratio for Tonghua Dongbao Pharmaceutical Co Ltd (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Tonghua Dongbao Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.80%	CN¥63.22 Million ≈ $9.25 Million	CN¥7.91 Billion ≈ $1.16 Billion	+0.05pp
2024-12-31	0.75%	CN¥55.40 Million ≈ $8.11 Million	CN¥7.38 Billion ≈ $1.08 Billion	+0.04pp
2023-12-31	0.71%	CN¥55.52 Million ≈ $8.12 Million	CN¥7.77 Billion ≈ $1.14 Billion	-0.15pp
2022-12-31	0.87%	CN¥58.46 Million ≈ $8.55 Million	CN¥6.75 Billion ≈ $987.78 Million	+0.30pp
2021-12-31	0.57%	CN¥37.00 Million ≈ $5.41 Million	CN¥6.52 Billion ≈ $954.10 Million	-2.02pp
2020-12-31	2.59%	CN¥150.37 Million ≈ $22.00 Million	CN¥5.80 Billion ≈ $849.20 Million	-3.32pp
2018-12-31	5.91%	CN¥323.00 Million ≈ $47.27 Million	CN¥5.46 Billion ≈ $799.46 Million	-0.65pp
2017-12-31	6.56%	CN¥312.00 Million ≈ $45.66 Million	CN¥4.75 Billion ≈ $695.47 Million	-1.99pp
2016-12-31	8.56%	CN¥400.00 Million ≈ $58.53 Million	CN¥4.68 Billion ≈ $684.10 Million	--

pp = percentage points

About Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.25 Billion

CN¥15.37 Billion CNY

Market Cap Rank

#5785 Global

#1089 in China

Share Price

CN¥7.85

Change (1 day)

+0.38%

52-Week Range

CN¥7.37 - CN¥10.49

All Time High

CN¥23.57